Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate Susceptibility in P. Falciparum Malaria
NCT01165372Phase 2Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in Plasmodium falciparum malaria, sponsored by Oxford University Clinical Research Unit. Started Aug 2010; status: completed.
02
Drugs
artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01165372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165372.